Plasma concentrations of inorganic sulfate in Alzheimer's disease. 1993

D J Edwards, and H J Altman, and R E Galinsky
College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, MI 48202.

Recent reports have suggested that plasma concentrations of inorganic sulfate may be lower in patients with Alzheimer's disease (AD). We measured sulfate concentrations in 10 patients with AD and found an average concentration of 0.28 mM, which was not significantly different from the mean concentration in age-matched controls (0.32 mM) or young healthy controls (0.27 mM). These results indicate that plasma sulfate concentrations are not altered in AD and that previous reports suggesting altered metabolism of sulfur-containing xenobiotics in neurodegenerative diseases should be reevaluated.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D013431 Sulfates Inorganic salts of sulfuric acid. Sulfate,Sulfates, Inorganic,Inorganic Sulfates

Related Publications

D J Edwards, and H J Altman, and R E Galinsky
June 1983, Journal of pharmaceutical sciences,
D J Edwards, and H J Altman, and R E Galinsky
January 1992, Biological psychiatry,
D J Edwards, and H J Altman, and R E Galinsky
January 2010, Archives of gerontology and geriatrics,
D J Edwards, and H J Altman, and R E Galinsky
September 1989, Lancet (London, England),
D J Edwards, and H J Altman, and R E Galinsky
January 1992, Journal of perinatal medicine,
D J Edwards, and H J Altman, and R E Galinsky
April 1988, Journal of clinical pathology,
D J Edwards, and H J Altman, and R E Galinsky
December 2006, The Lancet. Neurology,
D J Edwards, and H J Altman, and R E Galinsky
December 2006, The Lancet. Neurology,
D J Edwards, and H J Altman, and R E Galinsky
July 1986, Journal of pharmaceutical sciences,
D J Edwards, and H J Altman, and R E Galinsky
July 1981, Clinical nephrology,
Copied contents to your clipboard!